RxDoctor Payments Data

Matthew Lutz, DO

Otolaryngology/Facial Plastic Surgery · Stow, OHNPI 1104024595

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Inspire Medical Systems, Inc. accounts for 66.8% of it on its own, with 18 other manufacturers making up the rest.

$6,035in general payments, 2019–2025

Across 105 payments — averaging $57.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$4K
  • Sanofi$502
  • Regeneron Healthcare Solutions, Inc.$267
  • Optinose US, Inc.$193
  • Organogenesis Inc.$149
  • BD$148
  • plus $746 from 13 others

What the payments were for

  • Food & beverage$6,035100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,035 in reported general payments places this provider in the 85th percentile of 29 otolaryngology/facial plastic surgery providers in Ohio.

See all otolaryngology/facial plastic surgery providers in Ohio

Medicare billing

Part B allowed, 2024
$156,803
Medicare patients
391
Services billed
4,286

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab22$90,341
Epinephrine72$13,785
Ipratropium Bromide277$9,861
Azelastine Hcl126$2,900
Fluticasone Propionate149$2,012
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth21$1,553
Mometasone Furoate18$1,198
Omeprazole85$907
Fluocinolone Acetonide Oil25$836
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav43$710
Ofloxacin15$626
Nystatin19$583
Montelukast Sodium70$481
Mupirocin57$274
Prednisone42$181

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Stow

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →